Tripp Haston was quoted in Law360's January 1, 2013, article which reviewed high-stakes life sciences cases to be decided in 2013. The decisions may dramatically impact how pharmaceutical companies make their products, what they may patent, and how they address competition for their drugs. Haston co-chairs the BABC Life Sciences Industry Team and represents multi-national pharmaceutical and medical device manufacturers in products liability litigation on regional, national, and international engagements.